慕尼黑再保险披露2026年中报：利润超预期但再保险收入指引下调

55% off: Lock in InvestingPro for less than $2 a week BEFORE OUR SUMMER SALE ENDS
Introduction & Market Context
Munich Re (ETR:MUV2) presented its half-year 2026 financial results on August 7, delivering a robust earnings performance that exceeded prior-year levels even as the company trimmed its full-year revenue outlook to reflect softer reinsurance pricing conditions. The German reinsurance giant reported H1 2026 net income of €3.9 billion and maintained its full-year profit target of €6.3 billion, while reducing reinsurance revenue guidance by €2 billion to €38 billion.
The presentation, led by CEO Christoph Jurecka and CFO Andrew Buchanan, emphasized the company’s disciplined approach to underwriting and its increasingly diversified business model, which is helping Munich Re navigate a normalizing reinsurance pricing cycle while preserving profitability.
Executive Summary
Munich Re’s first-half performance demonstrated the strength of its multi-segment strategy, with the company achieving a 23.0% return on equity—well above its Ambition 2030 target of more than 18%. As illustrated in the following overview of the company’s H1 2026 performance:
The reinsurance segment delivered a net result of €3,369 million with a 24.9% return on equity, while ERGO contributed €556 million at a 15.8% ROE. These results positioned Munich Re to achieve more than 60% of its full-year profit target in just the first six months, reflecting what management described as "strong earnings delivery."
The company’s diversified business model showed its value during the period, with top-line growth varying significantly across segments. As demonstrated in the following breakdown of business segment contributions:
While P&C reinsurance saw an 11.3% decline in gross insurance revenue on an FX-adjusted basis, this was offset by a 6.3% increase from other segments, resulting in overall Group growth of 0.9%. Munich Re emphasized that it is "using its competitive advantage to manage the reinsurance cycle more rigorously," walking away from business that doesn’t meet profitability requirements.
Reinsurance Market Dynamics
The July 2026 renewals provided a clear picture of the evolving reinsurance market, with Munich Re facing its most challenging pricing environment since the hardening cycle began in 2022. The following chart illustrates the historical context and 2026 renewal dynamics:
Risk-adjusted prices declined 5.5% at the July renewals, marking the steepest drop in the current cycle, while volumes fell 9.1%. However, management stressed that "margins remain attractive despite softer pricing," with the price decline coming "from a very high level."
The company’s strategic response to these market conditions is illustrated in its portfolio optimization approach, shown in the following visualization of business line adjustments:
Munich Re took a particularly disciplined stance on Property XL business, reducing volume by approximately 20% while accepting a 7% price decline, "leveraging balance sheet and client partnerships while giving up unprofitable business." In contrast, the company maintained stable volumes in Property proportional and Casualty proportional lines by selectively growing in markets with good prospects while reducing exposure to less attractive segments.
Diversification Strategy Delivering Results
The company’s emphasis on building less cyclical revenue streams showed tangible benefits in H1 2026. Global Specialty Insurance, which Munich Re has been actively developing, demonstrated solid performance despite currency headwinds:
GSI achieved insurance revenue of €4.17 billion in H1 2026 (representing FX-adjusted growth of approximately 3%) and maintained a combined ratio of 86.3%, well within the expected range around 90%. The business is exploring new opportunities in US real estate, professional liability, and European surety markets, with management projecting 5-9% annual growth through 2030.
Life and Health reinsurance continued its strong earnings trajectory, as shown in the following performance overview:
The L&H segment delivered a total technical result of €1,028 million in H1 2026, tracking ahead of pro rata annual guidance. Munich Re completed a significant longevity deal covering €4 billion in pension liabilities and announced two large US transactions in Q3. The continuously growing Contractual Service Margin (CSM) stock, which reached €16.0 billion by June 30, provides visibility into future earnings.
ERGO’s consistent performance further demonstrated the value of diversification:
The primary insurance segment achieved a net result of €556 million in H1 2026, maintaining its trajectory toward the full-year target of approximately €0.9 billion. ERGO’s "digital first" approach and systematic AI deployment are providing efficiency gains, while strong market positions in Poland, Greece, and Belgium are driving profitable growth in international markets.
Investment Performance Driving Returns
A key factor in Munich Re’s strong H1 results was exceptional investment performance, benefiting from higher interest rates and active portfolio management. The following chart illustrates the structural improvement in investment returns:
The return on investment reached 4.2% in H1 2026, double the 2.1% achieved in 2022, driven by a running yield that increased from 2.4% to 3.6% over the same period. The reinvestment yield remained elevated at 4.3% in Q2 2026, supporting further increases in running yield without changing the portfolio’s risk profile.
Munich Re’s investment portfolio totaling €241 billion maintained a conservative profile while expanding alternative investments and capturing opportunities in emerging market currencies, Japanese equities, and US equities. The company’s detailed investment breakdown is shown below:
The portfolio’s diversification across government bonds (29%), corporate bonds (16%), alternative investments (18%), and other asset classes provided stable income while allowing the company to "actively capture market opportunities." Private equity investments delivered particularly strong performance in Q2 2026.
Comprehensive Financial Performance
The detailed quarterly and half-year results across all segments highlighted the breadth of Munich Re’s earnings power:
Q2 2026 net result of €2,211 million compared favorably to €2,085 million in Q2 2025, despite the softer reinsurance pricing environment. The total technical result of €5,221 million for H1 2026 exceeded the prior-year period’s €5,088 million, while the net financial result more than quadrupled from €213 million to €1,009 million.
P&C reinsurance benefited from exceptionally low major losses in Q2, with a major-loss ratio of just 4.9% compared to the expected level around 6-7%. The normalized combined ratio of approximately 82% in Q2 reflected recent renewal dynamics and business mix effects, which management expects to trend higher through the remainder of 2026.
Capital Position & Outlook
Munich Re’s capital strength remained a cornerstone of its competitive position, as illustrated in the following overview:
The Solvency II ratio stood at 304% as of June 30, 2026, well above the company’s target of more than 200% and providing substantial flexibility for capital management. Equity totaled €33.7 billion, with total capitalization reaching €42.1 billion when including the CSM and strategic debt.
Despite reducing its reinsurance revenue outlook, Munich Re maintained all key profit and return targets for 2026:
The company reaffirmed its net result target of approximately €6.3 billion for full-year 2026, with H1 results already representing more than 60% of this goal. The reduction in insurance revenue guidance from €64 billion to €62 billion (and reinsurance revenue from €40 billion to €38 billion) reflects the impact of July renewals and disciplined underwriting decisions rather than any deterioration in profitability.
Looking beyond 2026, Munich Re’s Ambition 2030 targets remain "fully intact," according to management:
The long-term strategy calls for return on equity exceeding 18%, earnings per share growth above 8% annually (CAGR 2025-2030), and a total payout ratio exceeding 80%. Management emphasized that increasing contributions from less cyclical segments—Global Specialty Insurance, Life & Health reinsurance, and ERGO—will reduce reliance on P&C reinsurance earnings and enable more rigorous cycle management.
The company’s three strategic pillars support these targets: managing the reinsurance cycle impact through strong investment results and balance sheet strength; leveraging diversification to stabilize earnings; and utilizing capital management flexibility to enhance EPS growth and ROE.
Segment Deep Dive
ERGO Germany demonstrated solid execution across both Life & Health and Property & Casualty businesses:
The segment achieved a net result of €392 million in H1 2026, driven by strong technical profitability and robust investment returns. The P&C combined ratio of 88.4% reflected good underwriting discipline, while the CSM remained stable at €9.9 billion, with new Life & Health contracts adding €107 million during the period.
ERGO International showed strong performance in major markets:
Net result reached €164 million in H1 2026, with the segment benefiting from the ERGO NEXT acquisition, which added €337 million to insurance revenue. Good organic growth in Poland and Belgium offset the impact of Spain’s MUFACE contract discontinuation, while the CSM increased to €2.9 billion, reflecting positive operating changes.
Life and Health reinsurance maintained its growth momentum:
The segment’s total technical result of €1,028 million in H1 2026 was supported by positive experience adjustments on in-force business and strong new business production. The CSM reached €16.0 billion by June 30, with solid contributions from new business and positive impacts from risk model parameter updates.
P&C reinsurance, while facing revenue headwinds, maintained strong profitability:
The combined ratio of 67.9% in H1 2026 (68.9% in Q2) benefited from major losses of just 4.9% in the second quarter, well below the expected level. However, the normalized combined ratio of approximately 82% in Q2 better reflects underlying profitability after adjusting for the unusually low catastrophe activity and one-time effects.
Global Specialty Insurance rounded out the reinsurance division’s performance:
The segment achieved a combined ratio of 86.3% in H1 2026, largely in line with full-year expectations, while generating FX-adjusted organic revenue growth of 2.6%. Ongoing expansion at HSB, AMIG, and Specialty Global Markets positions GSI for continued growth within its 5-9% annual target range through 2030.
Munich Re’s H1 2026 presentation underscored a company successfully navigating a transitional market environment through disciplined underwriting, strategic diversification, and strong investment management. While softer reinsurance pricing has reduced revenue expectations, the company’s focus on profitability over volume—combined with robust contributions from less cyclical business segments—has positioned it to achieve another record year of earnings in 2026.
Full presentation:
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.